Releases
24. March, 2021
Cessatech reports first subject dosed in bioavailability trial of lead product candidate
Clinical trial 0204 in healthy volunteers will investigate the absolute bioavailability of CT001. Primary...
Releases
9. March, 2021
Cessatech A/S is awarded Best Medical Treatment IPO Nordics in 2020 by independent editorial
CFI.co – a journal and online resource reporting on business, economics and finance –...
Releases
4. March, 2021
Favourable data from the Registry Safety Study
First major milestone reached: Data from the Registry Safety Study (0203) indicates a favourable...
Releases
11. February, 2021
Year-end report Q4-2020 – on track and accelerating clinical activities
Cessatech A/S today releases its results for the period 6. April – 31 December 2020. The company is on track with Q4 activities and getting...
Facts
2. February, 2021
Ny forskning: Barn bör få smärtlindring vid vaccinationer och injektioner
Barn mår bra av smärtlindring vid vanliga vaccinationer och injektioner. Det säger den senaste...
Releases
21. January, 2021
Supporting ‘Save the Children’
Cessatech has entered a corporate sponsorship with Save the Children. We want to make...
Media
27. November, 2020
Massiv interesse for børsnotering
Det nystiftede bioselskab Cessatech med en tidligere Lundbeck-direktør i spidsen og prominente folk i...
Releases
27. November, 2020
Cessatech’s IPO of units significantly oversubscribed
Subscribed to DKK 107 million, corresponding to a subscription ratio of approx. 680 percent....
Media
24. November, 2020
CESSATECH VILL BEDÖVA BARN VIA NÄSAN
STOCKHOLM (Nyhetsbyrån Direkt) Det danska forskningsbolaget Cessatech, som utvecklar behandlingar för barn, tänker ge...
Media
10. November, 2020
Cessatech mot börsen med nässpray mot smärta
Danska Cessatech har utvecklat en nässpray för smärtlindring speciellt anpassad för barn. Den ska...
Releases
6. November, 2020
Approval for IPO listing
Cessatech A/S today announces that Spotlight Stock Market’s listing committee has approved Cessatech’s application...
Facts
8. September, 2020
Behov for større sikkerhed omkring medicin til børn og unge i Danmark
Kun 30% af markedsførte lægemidler i EU er godkendt til børn, og kun 50%...